Amyloid-beta (monoclonal antibody) drugs for Alzheimer's Disease

9 tracked Amyloid-beta (monoclonal antibody) drugs in the Alzheimer's Disease race. The class explanation lives on the Amyloid-beta (monoclonal antibody) page; the full indication pipeline across every mechanism is on the Alzheimer's Disease page.

2 approved / phase 42 Phase 31 Phase 21 Phase 1/23 Phase 1

Head-to-head evidence: ABBV-1758 vs ALIA-1758 · ABBV-1758 vs CM383 · ABBV-1758 vs Donanemab · ABBV-1758 vs Lecanemab · ABBV-1758 vs Remternetug · ABBV-1758 vs SHR-1707

The roster

← all Amyloid-beta (monoclonal antibody) drugs